RPRX
Repros Therapeutics Inc.
RPRX
RPRX
Delisted
RPRX was delisted on the 31st of January, 2018.
72 hedge funds and large institutions have $135M invested in Repros Therapeutics Inc. in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $160M → $135M (-$24.9M)
53% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 15
Holders
72
Holding in Top 10
1
Calls
$9.51M
Puts
$4.11M
Top Buyers
| 1 | +$2.47M | |
| 2 | +$2M | |
| 3 | +$980K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$576K |
| 5 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$558K |
Top Sellers
| 1 | -$4.47M | |
| 2 | -$1.03M | |
| 3 | -$997K | |
| 4 |
Goldman Sachs
New York
|
-$913K |
| 5 |
HCM
Highbridge Capital Management
New York
|
-$897K |